Ko nozīmē “Notīrīt”?
Dzīvniekam nav mutācijas. Tas neattīstīs slimību un nenodos to tālāk.
Suns Austrālijas labradoodla distrofinopātija (DMD-AL)
Discover the Australian Labradoodle Dystrophinopathy (DMD-AL) DNA test, an essential tool for dog breeders and owners. This genetic test identifies the presence of mutations linked to DMD-AL, a condition affecting muscle strength and health in Australian Labradoodles. Early detection through DMD-AL testing can help prevent the onset of symptoms and guide responsible breeding practices. Ensure your furry friend’s well-being by opting for this crucial DNA test. By understanding your dog’s genetic profile, you can make informed decisions that promote a healthier, happier life. Trust the DMD-AL DNA test for a proactive approach to your Australian Labradoodle's health. Take action today to safeguard your pet's future!
Saīsinājums: DMD-AL
Analizētā mutācija: DMD c.2668C>T
Mantojums: X-Linked recesīvs
Akronīms
DMD-AL
Novērotā biežums
Klīniskā smaguma pakāpe
Klīniskā klasifikācija
Muskuļu slimības
Analizēta mutācija
DMD c.2668C>T
p.(R890*)
p.(R890*)
Mantojuma veids
X-Linked recesīvs
Alternatīvs nosaukums:
Duchenne Muscular Dystrophy In Australian Labradoodle
Testa kopsavilkums:
The Australian Labradoodle Dystrophinopathy (DMD-AL) is a genetic condition affecting Australian Labradoodles, characterized by a deficiency in dystrophin, a protein essential for muscle function. This DNA test helps identify carriers of the mutation responsible for the disease, allowing breeders to make informed decisions and reduce its prevalence. Early detection through genetic testing can lead to better management strategies and ensure healthier breeding practices. Responsible breeding can significantly improve the quality of life for affected dogs, promoting overall breed health. Owners and breeders are encouraged to utilize this test to support the wellbeing of future generations of Australian Labradoodles.
Pieejams no iepakojuma: Basic
Šis DNS tests ir iekļauts, sākot no mūsu iepakojuma Basic — un arī ir daļa no iepakojumiem Basic, Standard, Advanced, Complete.
Skatīt DNS testu pakotnes →Izvēlieties iepakojumu, kas vislabāk atbilst jūsu dzīvnieku audzēšanas vai veselības stratēģijai.
Understanding Australian Labradoodle Dystrophinopathy (DMD-AL)
Australian Labradoodle Dystrophinopathy (DMD-AL) is a genetic condition that affects the muscle function of Australian Labradoodles. This disorder is caused by mutations in the dystrophin gene, which is essential for maintaining the integrity of muscle fibers. As a result, affected dogs may experience progressive muscle weakness and degeneration, leading to significant mobility issues over time.
Symptoms of DMD-AL
Dogs with DMD-AL often exhibit a range of symptoms that can vary in severity. Common signs include difficulty in walking, reluctance to engage in physical activities, and noticeable muscle wasting. As the disease progresses, owners may observe a decline in the dog’s overall stamina and strength, which can severely impact their quality of life.
Diagnosis of DMD-AL
Diagnosis of DMD-AL typically involves a combination of clinical evaluation and genetic testing. Veterinarians may conduct physical examinations to assess muscle strength and function. Additionally, DNA testing can confirm the presence of the specific mutations associated with DMD-AL, providing a definitive diagnosis.
DNS testēšanas nozīme
DNA testing for DMD-AL is crucial for breeders and dog owners alike. For breeders, it helps in making informed decisions to avoid producing affected puppies, thus contributing to the overall health of the breed. For owners, knowing whether their dog is a carrier or affected allows for better management of the condition and planning for future care needs.
Management of DMD-AL
Currently, there is no cure for DMD-AL, but management strategies can help improve the quality of life for affected dogs. This may include physical therapy, nutritional support, and regular veterinary check-ups to monitor the progression of the disease. Owners should work closely with their veterinarians to develop a tailored management plan that addresses the specific needs of their dog.
Secinājums
Understanding Australian Labradoodle Dystrophinopathy (DMD-AL) is essential for responsible dog ownership and breeding practices. DNA testing plays a vital role in identifying affected and carrier dogs, enabling proactive measures to promote the health and well-being of this beloved breed. Awareness and education about DMD-AL can significantly enhance the lives of both dogs and their owners.
Pārbaudei atzītā šķirne: Austrālijas labradoodla distrofinopātija (DMD-AL)
- Labradoodle
🧬 Interpretation of genotypes DMD-AL
Genotips
Statuss
🟡 N/N
Nepārvadātājs — bez riska
❌ ♂ N/DMD-AL
Ietekmētie — apdraudēti
🟡 ♀ N/DMD-AL
Pārvadātājs — bez riska
❌ DMD-AL/DMD-AL
Ietekmētie — apdraudēti
FAQ: izpratne par interpretāciju
Vai “pārvadātājs” ir nopietns?
Nē. Dzīvnieks parasti ir vesels, bet var pārnest mutāciju uz savu pēcnācēji.
Ko darīt, ja dzīvnieks ir “ietekmēts”?
Tam ir divas mutācijas kopijas. Klīniskās pazīmes ir gaidāmas atkarībā no slimība. To nevajadzētu audzēt.
Kāpēc pastāv atšķirības starp vīrieti/sievieti?
Dažas slimības ir saistītas ar dzimumu, tāpēc to izpausme atšķiras atkarībā no dzīvnieka dzimums.
Paredzēt pēcnācējus
N/N (neparvadatajs)
N/DMD-AL (Pārvadātājs)
DMD-AL/DMD-AL (Ietekmētais)
Bieži uzdotie jautājumi par DNS testu
Ko atklāj šis DNS tests?
This DNA test detects the mutation associated with Australian Labradoodle Dystrophinopathy (DMD) in order to identify clear, carrier, or at-risk animals.
Kāpēc pārbaudīt vaislas dzīvnieku?
DNS testēšana palīdz selekcionāriem plānot drošāku pārošanos un samazina mutācijas pārnešanas risku pēcnācējiem.
Kāds ir šī testa mantojuma veids?
Šim testam norādītais mantojuma režīms ir X-Linked recesīvs.
Kura mutācija tiek analizēta šajā testā?
This test analyses the mutation DMD c.2668C>T.
Vai pārvadātājs dzīvnieks noteikti ir ietekmēts?
Nav obligāti. Interpretācija ir atkarīga no mantojuma modeļa un iegūtā genotipa.
Atsauces
Shrader Stephanie M, Jung SeungWoo, Denney Thomas S, Smith Bruce F. Characterization of Australian Labradoodle dystrophinopathy. Neuromuscul Disord. 2018 Nov;28(11):927-937. doi: 10.1016/j.nmd.2018.08.008. Epub 2018 Aug 29.